Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acrivon Therapeutics, Inc.

1.35
+0.10008.00%
Post-market: 1.34-0.0099-0.73%19:59 EDT
Volume:688.59K
Turnover:914.65K
Market Cap:42.33M
PE:-0.61
High:1.37
Open:1.26
Low:1.24
Close:1.25
Loading ...
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 11, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Correspondence

Form CORRESP - Correspondence
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Major Issues Report

Form 8-K - Current report